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A B S T R A C T
Bone grafting materials for repair of alveolar bone deﬁcits have improved markedly in recent years, increasing
the applicability and success of oral implantology. The long-term success rate of dental implant surgery is
strongly dependent on the quality and stability of residual bone tissue. Therefore, reconstruction of resorbed
alveolar bone is a challenge for clinicians. In the present study, we have developed bioactive bone regeneration
particles (BRPs) using amorphous calcium phosphate and 58S bioglass as raw materials. The structural char-
acteristics, biocompatibility, and osteoinductivity of these BRPs were compared to commercially available bo-
vine spongy bone (BSB) without organic components. X-ray diﬀractometry (XRD) and scanning electron mi-
croscopy (SEM) showed that BRPs were composed of β-tricalcium phosphate (β-TCP) and calcium silicate in the
form of hexagonal crystals, while BSB was mainly hydroxyapatite (HA) arranged in orderly nano-sized crystals.
The viability of human bone marrow mesenchymal stem cells (hBMSCs) cultured in BRP-containing medium was
roughly equal to that of hBMSCs in control medium. Moreover, hBMSCs in BRP medium exhibited greater
proliferation rates, substrate attachment, alkaline phosphatase (ALP) activity, alizarin red staining intensity, and
expression levels of osteogenic-related genes (COL-I, OCN, Runx-2, ALP, BSP) than hBMSCs in BSB medium,
indicating the superior osteoinductivity of BRPs. Silicon ions released from BRPs during cell culture were crucial
for these enhanced biological properties. BRPs also demonstrated superior osteoconduction and osteoinduction
properties for bone defect repair, suggesting promise for alveolar bone repair surgery.
1. Introduction
In recent years, widely application of bone grafting materials in the
defect of alveolar bone has been improved due to the development of
the oral implantology. The long-term success rate of dental implant
surgery depends to a great extent on suﬃcient alveolar bone mass
around the implant and integration between implant and circumjacent
natural bone. Therefore, implant surgery has higher requirements for
ambient bone tissue. The irreversible process of alveolar bone absorp-
tion can be easily caused by tooth loss, improper routine exodontia, bad
prosthesis or other factors, which leads to decreased alveolar bone
width and height, creating challenges for predictable implant
placement [1]. Moreover, insuﬃcient bone volume in the implant area
as well as reduces the success rate of dental implant surgery [2,3]. In
order to expand the application scope and success of oral implantology,
many researchers have sought to develop improved bone repair mate-
rials for regenerative treatment of bone deﬁciency.
Reconstruction of resorbed alveolar bone is a challenge for clin-
icians and a variety of bone repair materials has been applied in the
clinic. Autogenous bone, xenogenic bone and synthetic bone have
usually used in oral surgeries such as immediate or delayed augmen-
tation around implants, extraction sockets preservation after tooth ex-
tractions, alveolar ridge augmentation or reconstruction, etc [4–7].
Each of these materials has unique advantages and disadvantages.
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Autogenous bone, obtained from intraoral or extraoral donor sites, has
been extensively used due to its osteoconductive and osteoinductive
properties [8]. However, its high absorption rate usually compromise
the clinical outcomes. Indeed, both animal and human studies indicate
that around half of the autologous bone graft is absorbed within four
months [9,10]. Xenogeneic bone has extensive sources and its bone
structure is similar to natural bone. In addition, xenogeneic bone gen-
erally allows good osteoconduction, but implantation may result in
immunological rejection or non-healing of alveolar bone defect. Syn-
thetic bone grafts have good biocompatibility and biodegradability and
have a certain ability of osteoconduction. However, both xenogeneic
and synthetic bones lack suﬃcient osteoinductive capacity, resulting in
slower new bone formation. Given the advantages of synthetic bone
(reduce risk of rejection, potentially unlimited supply), it would be of
substantial clinical value to develop a synthetic bone material with
better osteoinductive function.
Currently, the xenogeneic bone most widely used in clinical practice
originates from bovine spongy bone (BSB), which is mainly composed
of hydroxyapatite (HA) without organic matter. The porous nature of
BSB allows for the growth of new bone tissue and provides a suitable
scaﬀold for bone tissue regeneration. However, little bovine spongy
bone can degrade in the defect site, and it remains in the form of foreign
matter for a very long time. The synthetic bone commonly used in
clinical practice is composed mainly of hydroxyapatite, calcium phos-
phate (TCP) or other materials. It has been proved that TCP has de-
monstrated good biocompatibility and appropriate biodegradability,
which is essential for adhesion and proliferation of bone cells [11].
Further, its chemical composition is similar to that of natural bone
tissue, so there are no obvious inﬂammatory reactions after implanta-
tion.
Silicon (Si)-containing biomaterials have achieved widely attention
due to the released Si ions have the function of inducing osteogenesis
and angiogenesis, promoting the repair of bone tissue and the formation
of new blood vessels [12,13]. In the study of Wang [14,15], silicate-
apatite composite layers precipitated on titanium rods demonstrated
increased osteoblastic proliferation and diﬀerentiation in vitro, and are
promising as coatings on external ﬁxation pins for decreasing the pin
tract infection rate in vivo. Bioglass (BG), one of the Si-containing
biomaterials, has also attracted much attention as a potential re-
generative material due to its biological activity and biocompatibility
[16,17]. Studies have shown strong ion exchange between bioglass and
bone tissue, so it can directly participate in the metabolism and re-
generation of new bone [18]. It can ultimately induce the growth of
new bone in the surface of bioglass material. The Ca, P, and Si ions
released from BG can help to form a strong chemical bond at the in-
terface with bone tissue, improving the interface integration between
the material and new bone [19]. However, pure bioglass has a rela-
tively faster degradation rate that does not match the growth rate of
new bone. A potential solution is the development of bioglass-con-
taining composite materials that retain the aforementioned advantages
of bioglass but with slower degradation kinetics.
In this study, we combined β-tricalcium phosphate (β-TCP) with
58S bioglass (60mol% SiO2-36mol% CaO-4 mol% P2O5) to adjust the
overall osteogenic properties and degradation rate. Subsequently, a
bulk precursor of the bone repair material required for oral implanta-
tion was prepared through freeze-lyophilization, followed by frag-
mentation and sintering to obtain bone repair particles with osteogenic
activity. The physicochemical properties and biosafety of the material
were tested and compared with the bovine spongy bone particles (BSBs)
commonly used in clinical practice. In vitro cell experiments and animal
implantation experiments were used to evaluate the osteogenic prop-
erties of the materials in detail.
2. Materials and methods
2.1. Preparation of amorphous calcium phosphate powder
Amorphous calcium phosphate (ACP) powder was synthesized by
chemical precipitation method using calcium nitrate (Ca(NO3)2·4H2O,
1.0 mol/L) and diammonium phosphate ((NH4)2HPO4, 0.8mol/L).
(NH4)2HPO4 solution was added into Ca(NO3)2·4H2O solution slowly at
room temperature with Ca/P ratio of 1.5, and ammonia water was
added into the mixed solution to control the pH value between 6.5–7,
yielding a white precipitate. After stirring for 5 h and aging for 24 h, the
white precipitate was harvested, washed with deionized water and
absolute ethyl alcohol, and oven dried. Final ACP powder with particle
size of less than 100 μm was recovered by sieving.
2.2. Preparation of bioglass powder
58S bioglass was prepared using sol-gel method. Tetraethyl ortho-
silicate (TEOS) and triethyl phosphate (TEP) were hydrolyzed in 2mol/
L nitric acid to form sol. And then calcium nitrate (Ca(NO3)2·4H2O) was
added into the sol under stirring condition until it was completely
dissolved. After aging for 48 h, drying for 5 days, heat treatment at
650 °C for 3 h, and ﬁnal grinding and sieving, bioglass powder (BG)
with a particle size of not more than 100 μm was obtained.
All the chemical reagents used in the synthesis of ACP powder and
58S bioglass powder were of AR grade and were commercially obtained
from Shanghai Aladdin Bio-Chem Technology Co., China.
2.3. Preparation of active bone regeneration particles
Polycaprolactone (weight-average molecular weight of 80,000) was
dissolved in dioxane under 90 °C water bath to obtain 20 wt% of a
polycaprolactone viscous solution. ACP and BG powders were added to
the polycaprolactone solution at a ACP to BG mass ratio of 3:2 and total
powder concentration in solution of 0.8 g/mL. A planetary ball mill was
used to mix the mixture to form homogeneous slurry. The uniformly
homogenized slurry was then subjected to a freeze-lyophilization pro-
cess to obtain a desired bulk precursor. The irregular particles, which
were obtained through fragmentation treatment, were sintered at
1250 °C for 2 h and sieved to obtain bioactive bone regeneration par-
ticles (BRPs) with a particle size range of 0.25–1mm.
2.4. Phase composition and micromorphology
Commercially available bovine spongy bone (BSB) was used as
control material. The BRPs and BSBs were ground into ﬁne powders,
and the phase compositions of BRP and BSB powders were analyzed by
X-ray diﬀractometer (XRD; X'Pert PRO; PANalytical Co., the
Netherlands) using CuKα radiation (λ=1.5418 Å) with 2θ from 10° to
70°. The scanning step size is 0.016° and ﬁnal data were analyzed using
X'Pert HighScore software.
The surface micromorphology of BRPs and BSBs was observed using
a scanning electron microscope (SEM; Nova NanoSEM 430, FEI, USA).
Brieﬂy, BRPs and BSBs were pasted on conductive tape and coated with
a thin layer of gold. Accelerating voltage of 15 kV was used for image
acquisition.
2.5. In vitro cell experiment
2.5.1. Preparation of BRP and BSB culture media
In this experiment, the eﬀects of BRP and BSB on the proliferation
and osteogenic diﬀerentiation of human bone marrow mesenchymal
stem cells (hBMSCs; HUXMA-01001, Cyagen, USA) were systematically
investigated using BRP- and BSB -containing culture media. The BRP
and BSB particles were sealed in centrifuge tubes and sterilized by 60Co
γ-irradiation with 20 kGy. Then complete culture medium (or
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osteogenic induction medium) at a particle weight-to-medium ratio of
0.2 g/mL was added into sample tubes. A real-time extraction process at
37 °C was carried out. Brieﬂy, the BRP and BSB soaking mediums were
completely collected and transferred separately to the relevant cell
culture plates every other day. The medium of the samples was renewed
with fresh medium immediately after removal.
The calcium and silicon ion contents in the collected media were
detected. Brieﬂy, the collected media were digestion using concentrated
nitric acid and the ions contents were tested using inductively coupled
plasma-atomic emission spectrometry (ICP-AES, Optimal 5300DV,
PerkinElmer, USA). Three replicate samples were prepared for each
treatment group at each time point.
2.5.2. Cytotoxicity and cell proliferation assays
Prior to cell seeding, hBMSCs were maintained in culture ﬂasks
under 95% humidity and a 5% CO2 atmosphere at 37 °C. Only hBMSCs
at passage 6 were used for experiments. Brieﬂy, cells were digested with
0.25% trypsin/EDTA (Gibco, 25200-056), resuspended in complete
culture medium (No.HUXMA-90011, Cyagen, USA), and seeded at the
indicated density. The medium was exchanged with BSB or BRP
medium as indicated after 4 h, which was then changed every second
day.
The cytotoxicity of BRPs was analyzed according to the protocol of
ISO 10993-5. Cells were resuspended and seeded on 48-well plates at 5
× 103 cell/well (500 μL cell suspension/well). The complete culture
medium was completely changed with BRP medium (prepared as de-
scribed) 4 h later. Cells cultured in complete culture medium were used
as a negative control. Four duplicate samples were prepared for each
treatment group. After 24 h of culture, the cytotoxicity of BRP was
examined using a Cell Counting Kit-8 (CCK-8 kit) according to the
manufacturer's protocol (Dojindo, Japan). Brieﬂy, the medium was re-
moved and 250 μL of CCK-8 working solution was added to each well.
After 1 h, 100 μL of the resulting orange-yellow supernatant in each
well was transferred to 96-well plates, and the optical density (OD)
value read at 405 nm using an enzyme-linked immune sorbent assay
(ELISA) plate reader. The same CCK-8 kit was used to monitor cell
proliferation. Brieﬂy, the assay was conducted after 1, 3, and 7 days of
culture. Four replicated were prepared for each treatment group.
For cell viability assays, cells were seed as described, incubated for
48 h in BRP or BSB medium and stained using the Viability/Cytotoxicity
Assay Kit for Animal Live & Dead Cells (Calcein-AM & Ethidium
homodimer-III; Biotium, NO.30002, USA). Brieﬂy, cells were washed 3
times with PBS to remove the residual medium, stained with ﬂuores-
cence staining working solution for 45min away from light. The stained
cells were washed 3 times with PBS, observed with an inverted ﬂuor-
escence microscope (Eclipse Ti2–U, Nikon, Japan), and the ﬂuorescence
images were taken with a charge-coupled device (CCD) camera.
The alkaline phosphatase (ALP) activity of hBMSCs cultured in BRP
and BSB osteogenic induction medium was evaluated by both ALP
staining and a quantitative biochemical assay. After 7 and 14 days in
culture (initial seeding density of 5 × 104 per well in 48-well plate),
cells were stained using BCIP/NBT substrate solution (NO.C3206,
Beyotime Biotechnology, China). Brieﬂy, cells were washed 3 times
with PBS and ﬁxed with 4% paraformaldehyde solution for 30min,
stained with staining working solution for half an hour, and then
washed with PBS to remove residual staining agent. Finally, the blue-
violet reaction product was observed with an inverted ﬂuorescence
microscope. ALP activity quantitative analysis was performed base on
the transformation from p-nitrophenyl phosphate (pNPP) to p-ni-
trophenyl (pNP) with the presence of ALP using an alkaline phospha-
tase activity test kit (NO.70-AP0011, MultiSciences, China). Cells
seeded as described and cultured for 7, 10, and 14 days were treated
according to the manufacturer's instructions with 4 replicates per
treatment group. The optical density was read using an ELISA plate
reader. The ﬁnal ALP activity is expressed as enzyme activity/total
protein.
Real-time quantitative polymerase chain reaction (RT-qPCR) was
used to detect osteogenesis-related genes expression levels of collagen
type I (COL-I), osteocalcin (OCN), runt-related transcription factor 2
(Runx-2), alkaline phosphatase (ALP), and bone sialoprotein (BSP) in
hBMSCs. Glyceraldehyde phosphate dehydrogenase (GAPDH) was used
as a house-keeping gene. The primer sequences of COL-I, OCN, Runx-2,
ALP, BSP and GAPDH are shown in Table 1. The cells were cultured in
6-well plates in BRP and BSB osteogenic induction medium (seeding
density of 2×105 cells per well). 3 replicate samples were prepared for
each treatment group. After 7 and 14 days of culturing, total RNA of
hBMSCs was extracted using HiPure Total RNA Kit (Magen, China)
following the manufacturer's guidelines. The Nanodrop 2000 (Thermo
Scientiﬁc) spectrophotometer was used to measure total RNA con-
centration. A cDNA Synthesis Kit (No.D7170 M, BeyoRT™ II, Beyotime
Biotechnology, China) was used to perform the RNA reverse tran-
scription. SYBR Green qPCR Mix (NO.D7260, BeyoFast™ II, Beyotime
Biotechnology, China) was used for the RT-qPCR reaction. The ther-
mocycle reaction was 30 s of DNA denaturation at 95 °C and 39 cycles
of 95 °C for 5 s and 60 °C for 30 s. The melting curve and Ct values were
obtained and analyzed using qTOWER3 software (Analytik Jena AG,
Germany). Expression levels were calculated based on the diﬀerence
between the target gene Ct value and the Ct value of DAPDH [2−ΔCt
where ΔCt=Ct (target gene) – Ct (DAPHD)].
Alizarin Red S (ARS) staining was used to detect the extracellular
matrix mineralization of hBMSCs cultured in BSB osteogenic induction
medium. After the cells were cultured for 14 days (5×104 cells per well
in 48-well plate), ARS (Sigma, A5533) was used to stain the calcium
nodules formed on the cell surface. Brieﬂy, cells were ﬁxed with 4%
paraformaldehyde solution for 30min and then rinsed with deionized
water for 3 times to remove residual formaldehyde solution. The cells
were stained with ARS working solution (40mmol/L, pH=4.2) for
10min under shaking, rinsed with deionized water until the residual
ARS stain is completely removed. The staining was observed using an
inverted ﬂuorescence microscope.
2.6. In-vivo animal experiment
Healthy New Zealand white rabbits from Guangdong Medical
Laboratory Animal Center were used to investigate the eﬃcacies of
BRPs and BSBs for bone regeneration. All procedures were approved by
the animal experimental ethics committee of Guangzhou Medical
University.
Six rabbits (3 males and 3 females, average body weight of 2.5 kg, 8
weeks of age) were randomly divided into two groups to investigated
Table 1
Primers used for RT-PCR analysis.
Target gene Forward primer sequences (5′-3′) Reverse primer sequences(3′-5′)
GAPDH AGAAAAACCTGCCAAATATGATGAC TGGGTGTCGCTGTTGAAGTC
Runx-2 AGATGATGACACTGCCACCTCTG GGGATGAAATGCTTGGGAACT
Collagen-I CAGCCGCTTCACCTACAGC TTTTGTATTCAATCACTGTCTTGCC
OCN TCACACTCCTCGCCCTATTG ACAGTCCGGATTGAGCTCAC
ALP ACATTCCCACGTCTTCACATTT AGACATTCTCTCGTTCACCGCC
BSP ATGGCCTGTGCTTTCTCAATG GGATAAAAGTAGGCATGCTTG
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two implantation times, 1 and 3 months. Anesthesia was performed by
intravenous injection of sodium pentobarbital (at a dose of 20mg/kg)
to the rabbit's ear vein. The anesthetized rabbit was ﬁxed on the op-
erating table. After depilated and thoroughly disinfected at the surgical
area of head, an skin incision about 20mm length was made on the
head, and the subcutaneous tissue, fascia, and periosteum were peeled
oﬀ layer by layer to expose the skull. Two circular defects 6-mm in
diameter were made in the skull at a distance not less than 5mm apart
using an electric drill. The endocranium under the skull was not da-
maged during the surgery. Bone debris in the skull defects was washed
out with sterile normal saline. The front defect was then ﬁlled with
BRPs (experimental group) and the posterior defect with BSBs (control
group). All samples were sterilized using 20 kGy γ-irradiation.
Autologous blood was drawn from the rabbit's ear vein for wetting the
sterile samples. Samples mixed with blood were ﬁlled into the defect
site. The front defect site of the skull was ﬁlled with BRP, while the
posterior defect was ﬁlled with the BSB. Barrier membrane, which was
commercially available collagen membrane, was used to cover on the
particles, with the membrane outer edges extending 2–3mm beyond
the edge of the defect. The periosteum, fascia, and outer skin were then
sutured layer by layer and the closed wound was disinfected with 75%
alcohol. After the operation, the rabbits were housed individually and
penicillin (40 wIU per day) was intramuscularly injected for 3 days as
anti-infection treatment. The overall surgical procedure is shown in
Fig. 1.
Rabbits were euthanized 1 month and 3 months after surgery, and
the bone tissue of the skull defect area was excised, ﬁxed with 10%
buﬀered formalin solution for at least 48 h, and examined as follows.
For 3 months implantation samples, a micro computed tomograph
(micro-CT) imaging system (XTV160H, X-TEK, UK) was used to scan the
microstructure at 60 kV and 67 μA. The scanning data were re-
constructed with Materialise Interactive Medical Image Control System
(Mimics) software to obtain the 3-dimensional images. For 1 and 3
months implantation samples, after decalciﬁed and embedded in par-
aﬃn, samples were cut into slices with thickness of 5 μmat the central
part of diameter position using a microtome (RM2016, Leica,
Germany). Slices were stained with hematoxylin-eosin (HE) and the
stained tissue was observed with optical microscope (DM1000, Leica,
Germany).
2.7. Statistical analysis
Data in this study were expressed as means ± standard deviation
for all experiments. Treatment group means were compared by
Student's t-test. P < 0.05 was considered to be statistically signiﬁcant
(*P < 0.05, **P < 0.01). All photographs were digitally processed
using Adobe Photoshop CS.
3. Results
3.1. Phase composition and micromorphology of BRPs and BSBs
Phase compositions of BRPs and BSBs were analyzed by comparing
the XRD patterns (Fig. 2) to Joint Committee on Powder Diﬀraction
Standards (JCPDS) cards. Results indicated that the main component of
BSB is HA (JCPDS reference code: 00-009-0432), and no secondary
phase could be found from the XRD patterns. BRPs were composed
mainly of β-tricalcium phosphate (β-Ca3(PO4)2 (JCPDS reference code:
00-009-0169). Moreover, the XRD analysis also showed that part of
calcium silicate (CaSiO3, JCPDS reference code: 00-001-0720) existed
in BRP samples.
Fig. 3 illustrates the micromorphology of BSBs and BRPs. The BSB
samples were three-dimensional porous sponge-like structures (Fig. 3A)
composed of nano-sized HA particles arranged in a directional order
(Fig. 3B). The BRP samples were three-dimensional porous and irre-
gular structures composed mainly of hexagonal crystals ranging in size
from 1 to 5 μm with micropores among the crystals (Fig. 3D). Moreover,
it seems like that the pores among the crystals were mostly ﬁlled with
amorphous substances.
Fig. 1. Rabbit skull defect construction and material implantation for bone regeneration.
1: skull defect construction; 2: mixing of materials (bovine spongy bone or bone regeneration particles) with autologous blood; 3: material implantation; 4: defect
covering with a barrier membrane; 5: suturing.
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3.2. Cytotoxicity of BRP and the eﬀect of BRP and BSB on the activity of
hBMSCs
The result of BRP cytotoxicity assays is shown in Fig. 4. The hBMSCs
were cultured for 24 h in the negative control group and BRP extrac-
tion. The cell viability was detected by CCK-8. The OD value of the
measured result was directly proportional to the number of cells. The
results showed that compared with the negative control, the activity of
BRP was 91.4% of that in the negative control group. But there's no
signiﬁcantly diﬀerence with the result of the negative control, in-
dicating that the BRP material essentially non-toxic (i.e., high bio-
compatibility). Further, hBMSC number continued to increase over 1, 4,
and 7 days in culture with BRPs (Fig. 5) and proliferation was actually
higher compared to cells cultured in BSB medium. The OD values after
one day were equivalent for BRP and BSBP groups, but were sig-
niﬁcantly higher in the BRP group on days 3 and 7.
After hBMSCs were cultured in diﬀerent meida for 2 days, the dis-
tribution and activity of cells were tested using Live/Dead staining
assay (Fig. 6). The number of living cells (green) was greater in BRP
medium than in BSB medium. Moreover, dead cells (red) were more
numerous in the BSB group than the BRP group. What's more, most of
the cells cultured in BSB medium were not spread and attached well
due to their round cell body. However, cells cultured in BRP medium
had a better spreading form and cell ﬁlopodia could be signiﬁcantly
observed.
3.3. Release behavior of ions from BRP and BSB particles
During hBMSC culture process, the BRP and BSB media were ex-
change for fresh media every other day and the calcium and silicon ion
contents in the removed media were detected using ICP-AES to estimate
release rates from BRPs and BSBs (Fig. 7). The free calcium ion content
of BRP medium was much higher than that of BSB medium
(60–120 ppm vs. 10–20 ppm). Similarly, the Si ion content of BRP
medium was between 40 and 55 ppm, while Si was barely detectable in
BSB medium. For BRP group, higher amount of Ca and Si ions released
at early extraction period than that in the late extraction stage.
Fig. 2. XRD patterns of BRP and BSB.
Fig. 3. SEM images of BSB (A and B) and BRP (C and D).
Fig. 4. Cytotoxicity of BRP (repeat number n=4).
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3.4. Eﬀects of BRP and BSB on osteogenic diﬀerentiation of hBMSCs
In the present study, alkaline phosphatase ALP activity, ALP
staining, osteogenic diﬀerentiation-related gene expression levels (COL-
I, Runx-2, ALP, OCN, BSP), and alizarin red staining intensity were
measured in hBMSC culture process to compare the osteogenic diﬀer-
entiation capacity of BRPs and BSBs.
The ALP activity of hBMSCs cultured in BRP or BSB medium for 7,
11, and 14 days is shown in Fig. 8. In both groups, ALP activity of
hBMSCs increased with the prolongation of culture time. During the
whole cell culture period, the ALP activity of the cells for BSB group
increased slowly with the prolongation of culture time, and the ALP
activity at 14 days did not increase substantially compared with that at
10 days. The BRP group had a signiﬁcant promotion eﬀect on the in-
crease of ALP activity and its ALP activity had a continuous increase
with the prolongation of culture time. At each detection time point, the
ALP activity of the cells for BRP group was signiﬁcant higher than that
of the cells for BSB group. The intensity of ALP staining (blue-violet)
also increased with time in culture for both groups but was greater at all
time points in the BRP group compared to the BSB group, indicating a
greater rate ALP secretion from hBMSCs cultured in BRP medium.
Expression levels of the osteogenic-related genes ALP and OCN were
also signiﬁcantly greater in the presence of BRPs than BSBs after 7 days
of culture as measured by RT-qPCR (Fig. 9), while after 14 days, ex-
pression levels of all measured genes were higher in the BRP group.
Finally, alizarin red staining (Fig. 10) was signiﬁcantly more intense in
day-14 hBMSCs cultured in BRP medium, indicating a greater number
of calcium nodules formed by extracellular matrix mineralization.
3.5. In-vivo evaluation of BRP and BSB
After the implantation of BRP and BSB materials, New Zealand
white rabbits were in good condition after operation, and no deaths
occurred. The wounds healed well and there were no abnormal secre-
tions at the wound site. All rabbits could move normally after 12–24 h
of recovery after operation.
Hematoxylin-eosin (HE) staining of rabbit skull tissue after 1M
implantation of BRP and BSB is shown in Fig. 11 After 1M implantation
of BRP, there was a certain amount of new bone formation inside the
defect, away from the autologous bone. From the 200X picture in
Fig. 11 it can be seen that new bone formed around the implanted
particles closely, and new woven bones gradually growing into the
inner pores of the particles. In addition, nascent vascular tissue was
observed. In contrast, the BSB group showed only a small amount of
new bone formation at the material-autologous bone interface and on
the BSB particle surfaces after one month, but none in the middle of the
defect.
After 3M implantation of BRP and BSB in rabbit skull defects,
samples were scanned using micro-CT and then the scanning data were
reconstructed into a three-dimensional image for analysis. It can be
seen from Fig. 12 the overall bone mineral density of the BRP group
defect site is higher than that of the BSBBSB group. The pores among
the internal implanted particles of the BRP group had been completely
ﬁlled by the newly formed bone, leading to a dense overall structure.
Alternatively, there were still numerous observable voids among the
implanted BSBs, leading to a loose overall structure and poor defect
healing. Excellent integration of new bone with ambient natural bone
was observed in both groups.
The HE staining images of the rabbit skull tissues implanted with
BRP and BSB samples for 3M are shown in Fig. 13. It can be observed
from Fig. 13 that the voids among BRPs were ﬁlled with new bone
tissue. And along with the biodegradation of BRP, more new bones
grew into the inner pores of particles. Compared to implants after one
month, both the size and connection of the trabecular bone were in-
creased. After 3M implantation, the BSB group exhibited little new
bone formation in the middle of the defect on the side close to the dura
mater. Although there was a small amount of new bone growing around
the BSB particles in other areas, most of the voids among the particles
were not ﬁlled with new bone.
4. Discussion
β-TCP has long been utilized as bone substitution material or as an
additive to other matrix materials due to its demonstrated bioactivity
and biodegradability [20]. However, its clinical utility is still limited by
low osteoinductivity. Si-containing materials are attractive alternatives
for bone regeneration as Si release can promote osteogenesis and apa-
tite formation [21]. In the present study, we developed bone re-
generation particles (BRPs) by sintered the mixture of amorphous cal-
cium phosphate (ACP) as the apatite source and 58S bioglass powder as
Fig. 5. Proliferation of hBMSCs after incubated in diﬀerent media for 1, 4, and
7 days (repeat number n= 4).
Fig. 6. Live/dead ﬂuorescence staining images of hBMSCs after cultured in diﬀerent meida for 2 days.
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Fig. 7. Ca and Si concentrations in BRP and BSB meida respectively during cell culture process (repeat number n= 3).
Fig. 8. ALP activity quantitative analysis and ALP staining of hBMSCs after incubated in diﬀerent soaking extractions for 7, 10, and 14 days (repeat number n=4).
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the Si source. Commercially available bovine spongy bone (BSB) was
used as control group to help understand the biological properties and
osteogenic availability of BRP. The main component of BSB is HA,
which was obtained by processing bovine spongy bone and didn't
contain any organic components, resulting in relatively slow degrada-
tion rate after implantation into natural bone defects. It can be seen
from the analysis of Fig. 2 that BRP was composed of β-TCP and CaSiO3.
During the heat treatment process, the crystallinity of amorphous cal-
cium phosphate gradually increased, and ﬁnally tricalcium phosphate
phase formed due to the Ca/P ratio was 1.5. ACP and 58S powders were
sintered at 1250 °C, which was a relatively higher heat treatment
temperature. During the sintering process, CaSiO3 appeared due to the
crystallization of 58S, forming a glass ceramic, which is in accordance
with previous report that CaSiO3 content increased gradually after 58S
being sintered at 1000 °C and 1200 °C [22].
Surface topography analysis of BRP and BSB was performed in the
experiment. BSB was derived from natural cancellous bone, so it was
three-dimensional porous sponge-like structure with orderly arranged
nano-sized HA particles, which is exactly the crystal arrangement of
natural bone [23]. BRP was also a three-dimensional porous irregular
particle. From the enlarged view, the crystal was mainly hexagonal,
with size between 1 μm and 5 μm, and some micropores existed among
the crystals. Moreover, it seems like that the areas among the crystals
were mostly ﬁlled with amorphous substances. This structural feature
may be caused by the liquefaction of the bioglass during the sintering
process. Bioglass had relatively lower melting temperature [24], and
Fig. 9. The expression of osteogenic-genes COL-I, Runx-2, ALP, OCN and BSP from hBMSCs cultured for 7 and 14 days (repeat number n=3).
Fig. 10. Alizarin Red S (ARS) staining pictures of hBMSCs cultured for 21 days. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the Web version of this article.)
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bioglass in the molten state may ﬂow into the pores between granules.
It has been reported that, many studies were carried out by adding
bioglass into hydroxyapatite scaﬀold to repair the cracks of the porous
scaﬀold that were formed during sintering process. Molten bioglass
could ﬁll the cracks of the scaﬀold, so that the strength of the scaﬀold
was greatly improved [25,26].
The cytotoxicity of BRPs was tested according to ISO 10993-5. As
shown in Fig. 4, the OD value of hBMSCs cultured in BRP soaking so-
lutions was no signiﬁcant diﬀerence with that of the negative control,
indicating that the BRP material was not cytotoxic. However, the results
showed that the activity of BRP was 91.4% of that in the negative
control group. When the BRP samples soaked in culture medium, a
certain amount of Si ions will be released, resulting in an alkaline en-
vironment [27]. Thus, these BRPs appear to be essentially non-toxic
against osteogenic cells. In addition, these particles in culture medium
demonstrated relatively stable Si and Ca release behavior and greater
total release rate compare to BSBs in medium (Fig. 7). The ion content
in the solution detected in the experiment was the total content released
within every two days. Due to the diﬀerent solubility of the chemical
composition of the materials, the content of calcium ions and silicon
ions in the BRP soaking solution was higher, while the content of cal-
cium ions in the BSB soaking solution was relatively lower. In fact,
almost no silicon was detected in the BSB medium, although the natural
bone contains silicon element. In the BRP medium, the ion content in
the early extraction period was slightly higher than in the late extrac-
tion stage. The release content of ions from BRP decreased at later stage
of soaking, possibly due to the reprecipitation of apatite on the surface
of samples, which would inhibit further Ca and Si release. Nonetheless,
the enhanced release was manifested by greater osteoinductivity and
extracellular matrix mineralization.
In addition to good biocompatibility, the BRPs also promoted
greater cell proliferation compared to BSBs (Fig. 5). The amount of cells
and cell proliferation rate of BRP group were signiﬁcantly higher than
those of BSB group, and there were signiﬁcant diﬀerences in the
amount of cells between the two groups. The cells uniformly distributed
on cell culture ﬂasks remained good activity after 2 days incubation in
soaking solutions. Cells cultured in BRP solutions had greater amount,
higher cell activity, and better spreading morphology than those of BSB
group. Studies have shown that the silicon ions with appropriate con-
centration have a signiﬁcant eﬀect on cell growth. In the ES Thian
study, HOBs showed a faster rate of proliferation and higher ability to
extracellular matrix mineralization on Si-HA coatings compared to pure
HA coatings [28]. Also SEM observation showed well hMSCs adhesion
and spreading on Si-containing materials surface [29]. And some stu-
dies have shown that the Si-containing apatite biomaterials can also
prevent any cell damage caused by external environmental changes
[30]. Therefore, the greater Si release capacity of BRPs may account for
the substantially better bioactivity, including osteoconductive function,
compared to BSBs.
Since the material is irregularly granulated, cell adhesion is not easy
to evaluate, so the adhesion of hBMSCs on the surface of the material
was not detected in this experiment. But the BRP material contains Si
Fig. 11. Histological examination (HE staining) of skull bone defects in rabbits after the implantation of BRP and BSB for 1 month.
Fig. 12. Micro-CT three dimensional reconstruction images of rabbit skull bone defects after the implantation of BRP and BSB for 3 months.
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element, and the silicon released from the material usually combined
with the oxygen atom and was able to form a silicon oxygen network
structure in the material. This structure can bind to metal elements in
proteins, thereby promoting the adsorption of proteins on the surface of
the material [31]. In turn, the proteins adsorbed on the surface of the
material can interact with integrins on the cell surface to mediate better
cell-substrate adhesion [32]. Therefore, we speculated that BRP mate-
rial would have excellent osteoconduction function after implantation
into natural bone by promoting the adhesion and migration of osteo-
blasts, resulting in better interface bonding and osteointegration. Pre-
vious studies have also reported that silicate ions released from silicon-
containing materials have an adhesion-enhancing eﬀect. Thian et al.
found that cells can spread better on Si-HA coatings than on pure HA
coatings, and immunoﬂuorescence staining revealed a large amount of
visible actin ﬁlament formation in the cytoplasm on Si-containing
coatings [32]. In addition, Si-containing HA promoted adhesion of
human osteoblasts (HOBs) on the surface of the material [33].
Osteogenic diﬀerentiation was also enhanced by BRPs compared to
BSBPs as evidenced by greater ALP activity, ALP staining, expression of
osteogenic diﬀerentiation-related genes (COL-I, Runx-2, ALP, OCN,
BSP), and alizarin red staining. Under the osteogenic stimulation of the
external environment, hBMSCs will enter into the stage of osteogenic
diﬀerentiation accompanied by the maturation and mineralization of
the extracellular matrix. ALP is one of the markers of early diﬀer-
entiation of cells, which is secreted during the maturity of extracellular
matrix and promotes the mineralization of matrix in the later stage
[34]. In this experiment, the ALP activity of hBMSCs cultured in BRP
and BSB soaking solutions was studied by quantitative analysis and
qualitative analysis. The BRP group has a signiﬁcant promotion eﬀect
on the increase of ALP activity. It can also be seen from the ALP staining
experiment that the blue-purple color of BRP group cells was deeper
than that of BSB group, indicating that the amount of ALP secreted by
cells in BRP group was higher than that in BSB group. Silicon ions have
a certain promoting eﬀect on the improvement of ALP activity. Studies
by CM Botelho et al. reported that Si increased ALP activity and total
protein content in osteoblasts in vitro [35]. Thus, the enhanced ALP
activity in hBMSCs cultured in BRPs likely also stemmed for greater Si
release.
Human BMSCs cultured in BRP medium also generated greater
numbers of calcium nodules via extracellular matrix mineralization
than cells grown in BSBP medium. Again, this was likely due to the
greater supply of calcium and silicon ions released from BRP samples.
Indeed, a previous study demonstrated that calcium silicate compounds
induced osteo-like apatite formation [36]. Compared to BSBs, BRPs also
enhanced expression of osteogenic genes as evidenced by RT-qPCR.
COL-I is the main component of extracellular matrix collagen, and COL-
I is also one of the marker genes expressed in early stage of osteogenic
diﬀerentiation. As a speciﬁc bone transcription factor, Runx-2 plays an
important role in new bone formation by promoting gene transcription
during osteogenic diﬀerentiation [37]. BSP is a bone-speciﬁc calcium-
binding glycoprotein that promotes apatite nucleation, calcium
binding, and nodule formation [29,38]. Finally, OCN is expressed in
late stages of osteogenic diﬀerentiation and is also closely related to the
mineralization of extracellular matrix. Runx-2 can also indirectly pro-
mote the mineralization of extracellular matrix [39]. Further, silicate-
containing calcium phosphate bioceramics can activate the Wnt/β-ca-
tenin signaling pathway, which plays an important role in osteogenic
diﬀerentiation [40,41], and this pathway may be activated due to the
release of Ca and Si [42,43]. Therefore, the relevant indicators related
to mineralization and the expression level of osteogenic genes were up-
regulated, which was closely related to the induction eﬀect of silicon.
To sum up, BRP has better osteogenic induction performance than BSB
particles.
Finally, the superior osteoinductivity of BRP was directly demon-
strated in a rabbit skull defect model. New bone grew around the BRP
samples, and some new bones grew into the pores of the particles as the
degradation of BRP. New bone formed at both the middle and the edge
of the defect, indicating that the new bone grew under both bone
conduction and osteoinduction mechanisms after BRP implantation.
The construction and formation of new blood vessel is the key to the
success of tissue repair. After implantation, there were many capillaries
in the defect area, indicating that new blood circulation system was
gradually formed during the repair of new bone tissue, thereby ensuring
transportation of oxygen and nutrients and excretion of tissue meta-
bolites in the new bone area. After 3M implantation of BRP material,
the gap between the particles has been basically ﬁlled by the new bone,
meaning a successful bone regeneration result. After one month after
BSB implantation, most of the new bone was wrapped around the BSB
particles, and there was no new bone found in the middle of the defect.
Three months after implantation of BRPs, however, the gap between the
particles had been ﬁlled by new bone, while there were still voids
among BSB particles, leading to a loose overall structure and poor de-
fect healing. Bone defect was repaired only through the bone conduc-
tion mechanism for BSB particles. Further, fewer capillaries were ob-
served in BSB-treated defects, limiting nutrient supply for growth.
While both groups showed good interface bonding at 3 months after
implantation, the presence of Si in the BRPs appears to have enhanced
osteogenic activity, resulting in a higher bone regeneration rate.
Fig. 13. Istological examination (HE stain) of skull bone defects of rabbits after the implantation of BRP and BSB for 3 month.
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5. Conclusion
ACP and 58S powders were used as raw materials to synthesize
novel bone regeneration particles (BRPs). A porous block precursor was
prepared by lyophilization and the ﬁnal bioactive bone particles were
obtained through fragmentation and heat treatment. Commercially
available bovine spongy bone without organic components was selected
as the control material for comparison. XRD and SEM analysis showed
that BRP was composed of β-TCP and calcium silicate with a micro-
structure formed by hexagonal 1–5 μm crystals, while BSBPs were
mainly composed of orderly arranged nano-sized HA crystals. In vitro
cell experiments showed that BRPs were non-toxic to human bone
mesenchymal stem cells (hBMSCs) and that hBMSC proliferated faster
in BRP-containing medium than BSB-containing medium. The regulated
ALP activity, alizarin red staining, and the expression level of osteo-
genic-related genes of BRP group indicating its superior os-
teoinductivity compared to BSB. Silicon ions were dissolved stably from
BRP samples during cell culture period, which played crucial roles in
cell biological function. BRP and BSBs. The BRPs also showed greater
bone repair eﬃcacy in a rabbit skull bone defect model through HE
staining and micro-CT analysis. Thus, BRP demonstrated superior os-
teoconduction and osteoinduction properties compared to BSBPs and so
may hold great promise for alveolar bone repair surgery.
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